TORONTO, April 23, 2012 /PRNewswire/ - The following B-Roll is available by Video On-Demand web download:
In 2011, 23,000 Canadian women were diagnosed with breast cancer - this is the second most common cause of cancer death in women.
Although a diagnosis with this aggressive disease can be devastating an estimated 85 per cent with early stage breast cancer have a chance of being alive and disease free in five years. Halaven is the latest treatment approved by Health Canada for metastatic breast cancer and is now available for Canadians. New treatments proven to prolong survival provide patients with options and hope - this is important to Canadian patients and their families. The development of Halaven was inspired by nature. It is the first agent in the halichondrin class of drugs - a synthetic analogue of the molecule. Halichondrin B is a substance identified in a black sea sponge that lives off the coast of Japan. Studies have shown it has anti-cancer effects on tumors, blocking cell division and leading to cell death.
Dr. Shailendra Verma
Various B Roll
WEB Video Preview and Download link:
TIME OF POSTING: 7:00 AM EST
DATE OF POSTING: April 24th
All video can be viewed by clicking on the link. Broadcast quality video is available for download by accredited journalists. Please contact [email protected] for access.
STATIONS, FOR FURTHER INFORMATION, PLEASE CALL:
For assistance with Video On-Demand, please contact CNW at [email protected] or (416) 863-5612.
CNW Video On-Demand http://cnw.pathfireondemand.com provides free, secure and easy-to-use broadcast quality material direct from our website to accredited journalists worldwide.
This material is offered for free and unrestricted news use.
CNW VIDEO SERVICES.
SOURCE CNW Broadcast Services
Video with caption: "Video: B-Roll - Video: New Treatment Option HalavenT, Significantly Prolongs Overall Survival in Pre-treated Metastatic Breast Cancer Patients". Video available at: http://stream1.newswire.ca/cgi-bin/playback.cgi?file=20120424_C8358_VIDEO_EN_12643.mp4&posterurl=http://photos.newswire.ca/images/20120424_C8358_PHOTO_EN_12643.jpg&clientName=CNW%20Broadcast%20Services&caption=Video%3A%20B%2DRoll%20%2D%20Video%3A%20New%20Treatment%20Option%20HalavenT%2C%20Significantly%0D%0AProlongs%20Overall%20Survival%20in%20Pre%2Dtreated%20Metastatic%20Breast%20Cancer%20Patients&title=CNW%20BROADCAST%20SERVICES%20%2DVIDEO%20B%2DROLL%20AVAILABLE%20VIA%20CNW%20%2D%20New%20Treatment%20Option%20Significantly%20Prolongs%20Overall%20Survival%20in%20Pre%2Dtreated%20Metastatic%20Breast%20Cancer%20Patients&headline=%2FR%20E%20P%20E%20A%20T%20%2D%2D%20VIDEO%20B%2DROLL%20AVAILABLE%20VIA%20CNW%20%2D%20New%20Treatment%20Option%20Significantly%20Prolongs%20Overall%20Survival%20in%20Pre%2Dtreated%20Metastatic%20Breast%20Cancer%20Patients%2F